bioTheranostics Appoints Three Key Executives  
8/27/2013 6:32:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

bioTheranostics, Inc., a leading provider of molecular diagnostic solutions for metastatic cancer, today announced the addition of three industry veterans to its senior management team as it prepares for further commercial expansion and launch of its Breast Cancer IndexSM (BCI) molecular test. Gail Sloan joins the company as chief financial officer, Macey Johnson, III, as vice president of managed care and reimbursement, and Matt Sargent as Breast Cancer Index commercialization leader.

Help employers find you! Check out all the jobs and post your resume.